Antagonists of the toll-like receptor 1/2 complex
    6.
    发明授权
    Antagonists of the toll-like receptor 1/2 complex 有权
    toll样受体1/2复合物的拮抗剂

    公开(公告)号:US09517993B2

    公开(公告)日:2016-12-13

    申请号:US14417676

    申请日:2013-07-29

    发明人: Hang Yin Kui Cheng

    摘要: Provided are compounds, compositions and methods for treating Toll-like receptor 1/2 complex (TLRI/2) related inflammatory disorders. Small molecules, based on the benzotropolone scaffold, capable of influencing downstream signaling are disclosed as well as methods of making and modifying these molecules. Also provided are methods for treating a subject for a clinical condition associated with Toll-like receptor complex 1/2 activation, comprising administering to the subject an effective amount of a benzotropolone compound.

    摘要翻译: 提供用于治疗Toll样受体1/2复合物(TLRI / 2)相关炎性疾病的化合物,组合物和方法。 公开了能够影响下游信号传导的基于苯佐洛尔酮支架的小分子,以及制备和修饰这些分子的方法。 还提供了用于治疗与Toll样受体复合物1/2活化相关的临床病症的受试者的方法,包括向受试者施用有效量的苯佐溴酮化合物。